NIH to evaluate remdesivir treatment for COVID during pregnancy

WASHINGTON (NEWS10) — The National Institutes of Health (NIH) is funding a study into the effects of prescription remdesivir on those who are both pregnant and COVID-positive. Called “IMPAACT 2032,” the study, conducted at 17 sites in the U.S., will examine how pregnant people metabolize and digest the drug, and whether it poses side effects. […]

2020 Archive - UM School of Medicine Researchers Test Remdesivir

Phase III Trial to Study Combination of Genentech's Actemra

Policy Actions for the US Government to Accelerate Access to Oral

Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid

Management of Patients With COVID-19

Remdesivir Fails to Prevent Covid-19 Deaths in Huge Trial - The

Federal Response to COVID-19: Therapeutics CIG

Coronavirus Drug and Treatment Tracker - The New York Times

Messages from the COVID-19 Response Task Force